Evidence map›Paper›PMID 34165837›Full record

ArticleJournal of clinical laboratory analysis2021

Utility of process capability indices in assessment of quality control processes at a clinical laboratory chain.

Ping Dong, Yong-Bo Wang, De-Zhi Peng, Jia-Jia Wang, Ya-Ting Cheng, Xiao-Yan Deng, Biao Zheng, Ran Tao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ping DongLaboratory Diagnosis Department, Jinan KingMed Center for Clinical Laboratory, Jinan, China.
Yong-Bo WangLaboratory Diagnosis Department, Qingdao KingMed Center for Clinical Laboratory, Qingdao, China.
De-Zhi PengLaboratory Diagnosis Department, Jinan KingMed Center for Clinical Laboratory, Jinan, China.
Jia-Jia WangLaboratory Diagnosis Department, Jinan KingMed Center for Clinical Laboratory, Jinan, China.
Ya-Ting ChengLaboratory Diagnosis Department, Guangzhou KingMed Center for Clinical Laboratory, Guangzhou, China.
Xiao-Yan DengKingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China.
Biao ZhengKingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China.
Ran TaoLaboratory Diagnosis Department, Guangzhou KingMed Center for Clinical Laboratory, Guangzhou, China.ORCID https://orcid.org/0000-0003-1126-6050
Kingmed Diagnostics · CNQingdao Center of Resource Chemistry and New Materials · CN

Funding

Guangdong Medical Science and Technology Research Fund A2020597
6 · The paper itself

Abstract

backgroundTo evaluate the utility of the process capability indices C

methodsIn April 2020, the minimum C

resultsA total of 627 datasets of 33 assays from 19 laboratory facilities were collected for further analysis. Based on the C

conclusionProcess capability indices are useful for evaluating the quality control procedures in laboratory facilities and can help improve the precision and trueness of laboratory tests.

Indexed as

Quality ControlBlood Chemical AnalysisChinaHumansLaboratories, Clinicalimprovementprecisionprocess capability indexquality controltrueness

Identifiers

PMID34165837
PMCPMC8373361
OpenAlexW3175822657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.